BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.34.2.1783839887//EN
X-ORIGINAL-URL:https://alum.up.edu.ph/
X-WR-CALNAME:UP Alumni Website
X-WR-CALDESC:
X-WR-TIMEZONE:Asia/Manila
BEGIN:VTIMEZONE
TZID:Asia/Manila
X-LIC-LOCATION:Asia/Manila
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:PST
DTSTART:20260712T150447
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-4e85fa3a7bb64fffde3307ca72f2aeb5@alum.up.edu.ph
DTSTART;TZID=Asia/Manila:20260710T120000
DTEND;TZID=Asia/Manila:20260710T130000
DTSTAMP:20260710T075426Z
CREATED:20260710
LAST-MODIFIED:20260710
PRIORITY:5
SEQUENCE:3
TRANSP:OPAQUE
SUMMARY:Health Updates Webinar #291 (Nasaan ang pag-asa sa kanser sa obaryo?)
DESCRIPTION:\n\nThe University of the Philippines,\nin partnership with the UP Manila – National Institutes of Health,\nand in cooperation with UP Philippine General Hospital and UP College of Medicine,\nwould like to invite you to attend this webinar!\n \nRegistration slots are limited to this HEALTH UPDATES webinar\nSo sign up NOW:\nbit.ly/HealthUpdatesWebinar291 ( http://bit.ly/HealthUpdatesWebinar291 )\nWebinar #291\nJuly 10, 2026 (Friday), 12:00 noon\n“Nasaan Ang Pag-asa sa Kanser sa Obaryo?”\n\nPresenter:\nDr. Jean Anne B. Toral\nProfessor, Division of Gynecologic Oncology\nDepartment of Obstetrics and Gynecology, UP – Philippine General Hospital\nDirector, Office of Research Integrity, UP Manila\n\n———————————————————–\n\nWebinar #291\nJuly 10, 2026 (Friday), 12:00 noon\n“Nasaan Ang Pag-asa sa Kanser sa Obaryo?”\n\nThe landscape of gynecologic oncology is undergoing a profound transformation, driven by breakthroughs in molecular diagnostics, targeted therapeutics, and innovative screening strategies. Maintaining a contemporary understanding of these clinical advancements is pivotal to optimizing patient outcomes. Ovarian cancer remains one of the most formidable malignancies of the female reproductive system, often termed a silent threat due to its insidious onset and the subtle, non-specific nature of its early clinical manifestations.\n\nIn this week’s episode, we will explore the evolving paradigms of ovarian carcinogenesis by shifting from a singular disease model to a complex spectrum of distinct histopathological and molecular subtypes. We will learn comprehensive insights into the clinical utility of biomarkers such as Cancer Antigen 125 and Human Epididymis Protein 4, alongside the expanding role of genetic testing for BRCA1, BRCA2, and homologous recombination deficiency mutations. Understanding these genetic landscapes is no longer exclusive to tertiary subspecialists; it is now essential for frontline clinicians who spearhead risk assessment, patient counseling, and early referral pathways. In addition, we will attempt to demystify modern therapeutic modalities, including the strategic deployment of poly (ADP-ribose) polymerase inhibitors and anti-angiogenic agents in both primary maintenance and recurrent settings.\n\nOur speaker is Dr. Jean Anne B. Toral, who is a professor from the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UP-PGH. She also serves as Director of the Office of Research Integrity at UP Manila.\n\nJoin us to learn how to develop a collaborative network needed to combat ovarian malignancy and elevate the standard of women’s healthcare in the Philippines.\n
URL:https://alum.up.edu.ph/events/health-updates-webinar-291/
END:VEVENT
END:VCALENDAR